Indian startup Boltzmann Labs makes a chemistry studio for discovering novel small molecules and exploring chemical spaces with generative AI. The startup’s studio, BoltChem, creates QSAR property models using machine learning and deep learning. Its AI-based synthesis planning tool, ReBolt, also simplifies reaction pathway design. Additionally, the startup’s BoltBio, a target identification platform, utilizes multi-omics analysis, knowledge graphs, and neural networks to accelerate treatment for rare and common diseases.